Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | -1.93% | -10.55% | -22.77% |
Mar. 13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
Mar. 12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.77% | 258M | |
+72.64% | 12.34B | |
-18.30% | 7.96B | |
+15.38% | 7.16B | |
+2.18% | 5.72B | |
+6.51% | 5.03B | |
+21.99% | 4.35B | |
-22.19% | 3.99B | |
-41.36% | 2.21B | |
+0.87% | 2.01B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Bioventus Enters Contract to Allow Cigna's Commercial Plan Members Access to Knee Osteoarthritis Pain Treatments